Acadia Healthcare Company, Inc. (NASDAQ:ACHC) was the target of a significant drop in short interest during the month of October. As of October 31st, there was short interest totalling 12,678,708 shares, a drop of 24.0% from the October 13th total of 16,684,474 shares. Approximately 15.0% of the shares of the stock are short sold. Based on an average trading volume of 3,262,468 shares, the short-interest ratio is currently 3.9 days.
A number of equities analysts have issued reports on the company. Craig Hallum reiterated a “buy” rating and issued a $65.00 price objective (up previously from $52.00) on shares of Acadia Healthcare in a report on Monday, July 31st. Deutsche Bank AG increased their price objective on Acadia Healthcare from $58.00 to $60.00 and gave the stock a “buy” rating in a report on Monday, July 31st. UBS AG reiterated a “positive” rating and issued a $60.00 price objective (up previously from $54.00) on shares of Acadia Healthcare in a report on Monday, July 31st. Zacks Investment Research downgraded Acadia Healthcare from a “buy” rating to a “hold” rating in a report on Tuesday, August 1st. Finally, BidaskClub downgraded Acadia Healthcare from a “buy” rating to a “hold” rating in a report on Monday, July 31st. Two investment analysts have rated the stock with a sell rating, six have given a hold rating and nine have assigned a buy rating to the stock. Acadia Healthcare presently has an average rating of “Hold” and a consensus price target of $45.15.
In related news, CEO Joey A. Jacobs sold 500,000 shares of the firm’s stock in a transaction on Tuesday, August 22nd. The stock was sold at an average price of $50.69, for a total value of $25,345,000.00. Following the completion of the sale, the chief executive officer now owns 201,496 shares of the company’s stock, valued at $10,213,832.24. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, COO Ronald Morgan Fincher sold 80,000 shares of the firm’s stock in a transaction on Tuesday, August 22nd. The stock was sold at an average price of $50.69, for a total value of $4,055,200.00. Following the completion of the sale, the chief operating officer now directly owns 59,071 shares of the company’s stock, valued at approximately $2,994,308.99. The disclosure for this sale can be found here. Insiders have sold 1,824,040 shares of company stock worth $92,460,588 over the last quarter. Company insiders own 11.10% of the company’s stock.
A number of hedge funds and other institutional investors have recently added to or reduced their stakes in ACHC. BlackRock Inc. increased its holdings in Acadia Healthcare by 27,497.3% in the 1st quarter. BlackRock Inc. now owns 5,145,786 shares of the company’s stock worth $224,356,000 after buying an additional 5,127,140 shares in the last quarter. William Blair Investment Management LLC increased its holdings in Acadia Healthcare by 1,247.4% in the 2nd quarter. William Blair Investment Management LLC now owns 2,128,972 shares of the company’s stock worth $105,129,000 after buying an additional 1,970,965 shares in the last quarter. Janus Henderson Group PLC bought a new stake in Acadia Healthcare in the 2nd quarter worth about $74,805,000. State Street Corp increased its holdings in Acadia Healthcare by 95.2% in the 2nd quarter. State Street Corp now owns 1,998,030 shares of the company’s stock worth $98,667,000 after buying an additional 974,524 shares in the last quarter. Finally, Dimensional Fund Advisors LP increased its holdings in Acadia Healthcare by 107.3% in the 2nd quarter. Dimensional Fund Advisors LP now owns 1,486,643 shares of the company’s stock worth $73,412,000 after buying an additional 769,333 shares in the last quarter.
Acadia Healthcare (NASDAQ ACHC) opened at $27.79 on Wednesday. Acadia Healthcare has a twelve month low of $27.44 and a twelve month high of $54.34. The company has a current ratio of 1.36, a quick ratio of 1.36 and a debt-to-equity ratio of 1.30. The firm has a market capitalization of $2,496.80, a price-to-earnings ratio of 12.41, a PEG ratio of 1.05 and a beta of 0.89.
Acadia Healthcare (NASDAQ:ACHC) last issued its quarterly earnings results on Tuesday, October 24th. The company reported $0.58 earnings per share for the quarter, missing the consensus estimate of $0.65 by ($0.07). Acadia Healthcare had a net margin of 6.07% and a return on equity of 8.57%. The company had revenue of $716.70 million for the quarter, compared to the consensus estimate of $728.86 million. During the same quarter in the previous year, the business earned $0.58 earnings per share. Acadia Healthcare’s revenue was down 2.4% compared to the same quarter last year. sell-side analysts anticipate that Acadia Healthcare will post 2.23 EPS for the current fiscal year.
TRADEMARK VIOLATION NOTICE: “Acadia Healthcare Company, Inc. (ACHC) Sees Large Drop in Short Interest” was first reported by Markets Daily and is the sole property of of Markets Daily. If you are reading this report on another website, it was copied illegally and reposted in violation of US & international trademark & copyright laws. The correct version of this report can be read at https://www.themarketsdaily.com/2017/11/15/acadia-healthcare-company-inc-achc-sees-large-drop-in-short-interest.html.
About Acadia Healthcare
Acadia Healthcare Company, Inc is a provider of behavioral healthcare services, with operations in the United States and the United Kingdom. The Company focuses on acquiring and developing behavioral healthcare facilities. The Company operates through two segments: U.S. Facilities and U.K. Facilities.
Receive News & Ratings for Acadia Healthcare Company Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare Company Inc. and related companies with MarketBeat.com's FREE daily email newsletter.